Knowledge of Adolescent Well-care Visits and Attitudes Amongst Physicians
Launched by ABU DHABI HEALTH SERVICES COMPANY · Nov 15, 2024
Trial Information
Current as of October 30, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study in Al Ain, United Arab Emirates, is an observational, quality‑improvement project that looks at how well pediatricians and family medicine doctors understand and approach adolescent well‑care visits. Researchers will survey doctors online about what they know (based on Bright Futures guidelines) and how they feel about these visits. The survey has 36 questions and uses both knowledge questions and attitude statements. Doctors will take a first online survey, then receive short online educational material, and complete a second survey about 1 year later to see if the education improves knowledge and attitudes.
Who can participate? About 100 pediatricians and family medicine physicians who work at SEHA hospitals in Al Ain City can be invited to take part. Participation is by invitation (not random), and only doctors at Al Ain SEHA hospitals are eligible. This study does not involve patients directly and there is no drug or device being tested. It’s being conducted at Tawam Hospital and is not yet showing results; the goal is to learn whether the education helps doctors provide better adolescent well‑care visits and potentially improve satisfaction for teens and their families. Completion is estimated for June 30, 2025.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatricians and family medicine physicians at Al Ain City SEHA Hospitals.
- Exclusion Criteria:
- • Pediatricians and family medicine physicians who are not part of Al Ain City SEHA Hospitals.
About Abu Dhabi Health Services Company
Abu Dhabi Health Services Company (SEHA) is a leading healthcare provider in the United Arab Emirates, committed to delivering high-quality medical services and advancing healthcare innovation. As a prominent sponsor of clinical trials, SEHA focuses on enhancing patient care through rigorous research and development initiatives. The organization collaborates with local and international partners to facilitate studies that address critical health challenges, ensuring adherence to the highest ethical and regulatory standards. By fostering an environment of scientific inquiry, SEHA aims to contribute to the global medical community and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Ain, Abu Dhabi, United Arab Emirates
Patients applied
Trial Officials
Alaa S Mehair, MD
Principal Investigator
Abu Dhabi Health Services Co. -SEHA
Najla S AlKuawiti, MD
Study Chair
Abu Dhabi Health Services Co-SEHA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported